These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8395488

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
    Blanchet M, Sheppard R, Racine N, Ducharme A, Curnier D, Tardif JC, Sirois P, Lamoureux MC, De Champlain J, White M.
    Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
    Bounhoure JP, Bottineau G, Lechat P, Garnham J, Lapeyre G.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure.
    Cleland JG, Shah D, Krikler S, Frost G, Oakley CM.
    Am J Cardiol; 1992 Oct 08; 70(10):55C-61C. PubMed ID: 1329475
    [Abstract] [Full Text] [Related]

  • 30. [The ATLAS study (Assessment of Treatment with Lisinopril and Survival); justification and objectives].
    Komajda M, Wimart MC, Thibout E.
    Arch Mal Coeur Vaiss; 1994 Jun 08; 87 Spec No 2():45-50. PubMed ID: 7864722
    [Abstract] [Full Text] [Related]

  • 31. Study of the safety and efficacy of ACE inhibitors and their effects on 24-hour electrocardiographic monitoring in the treatment of moderate-to-severe heart failure: an interim analysis.
    Adgey J, Clarke M, Raza A, Meddis D.
    Am J Cardiol; 1992 Oct 08; 70(10):142C-144C. PubMed ID: 1329471
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study.
    Cleland JG, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Rydén L.
    Eur J Heart Fail; 1999 Mar 08; 1(1):73-9. PubMed ID: 10937983
    [Abstract] [Full Text] [Related]

  • 34. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH, Suter A, Weber M, Saller R.
    Phytomedicine; 2003 Mar 08; 10(5):363-9. PubMed ID: 12833999
    [Abstract] [Full Text] [Related]

  • 35. Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.
    Cleland JG, Shah D, Krikler S, Dritsas A, Nihoyannopoulos P, Frost G, Oakley CM.
    Br Heart J; 1993 Jun 08; 69(6):512-5. PubMed ID: 8393685
    [Abstract] [Full Text] [Related]

  • 36. A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients.
    Cooke GA, Williams SG, Marshall P, Al-Timman JK, Shelbourne J, Wright DJ, Tan LB.
    Eur Heart J; 2002 Sep 08; 23(17):1360-8. PubMed ID: 12191747
    [Abstract] [Full Text] [Related]

  • 37. Lisinopril: a review of its use in congestive heart failure.
    Simpson K, Jarvis B.
    Drugs; 2000 May 08; 59(5):1149-67. PubMed ID: 10852646
    [Abstract] [Full Text] [Related]

  • 38. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
    Cugno M, Agostoni P, Mari D, Meroni PL, Gregorini L, Bussotti M, Anguissola GB, Donatelli F, Nussberger J.
    Br J Haematol; 2005 Jul 08; 130(1):113-20. PubMed ID: 15982353
    [Abstract] [Full Text] [Related]

  • 39. A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
    Powers ER, Chiaramida A, DeMaria AN, Giles TD, Hackshaw B, Hart W, Haugland M, Johnston R, Katz R, Kirlin P.
    J Cardiovasc Pharmacol; 1987 Jul 08; 9 Suppl 3():S82-8. PubMed ID: 2442559
    [Abstract] [Full Text] [Related]

  • 40. Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure.
    Mulligan IP, Fraser AG, Lewis MJ, Henderson AH.
    Br Heart J; 1989 Jan 08; 61(1):23-8. PubMed ID: 2537095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.